Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

Journal of Clinical and Experimental Neuropsychology

Volumn 26, Issue 7, 2004, Pages 955-969

  Castellon, Steven A ^a,b,c   Ganz, Patricia A ^a   Bower, Julienne E ^a   Petersen, Laura ^a   Abraham, Laura ^a   Greendale, Gail A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; ANXIETY; ARTICLE; ATTENTION; BREAST CANCER; CANCER ADJUVANT THERAPY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MENTAL STRESS; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESPONSE TIME; SELF REPORT; TASK PERFORMANCE; VERBAL BEHAVIOR; VERBAL MEMORY; VISUAL MEMORY;

ADULT; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SURVIVORS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 9644289272     PISSN: 13803395     EISSN: None     Source Type: Journal    
DOI: 10.1080/13803390490510905     Document Type: Article

References (53)

1. Ahles, T. A., & Saykin, A. J. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19, 821-820.
2. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
3. Arpels, J. C. (1996). The female brain hypoestrogenic continuum from premenopausal syndrome to menopause. Journal of Reproductive Medicine, 41, 633-639.
4. Asthana, S., Baker, L. D., Craft, S., Stanczyk, F. Z., Veith, R. C., Raskind, M. A., et al. (2001). High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology, 57, 605-612.
5. Beck, A. T. et al. (1996). Beck Depression Inventory, 2nd Edition. San Antonio, TX: Psychological Assessment Resources.
6. Blair, J. R., & Spreen, O. (1989). Predicting premorbid IQ: A revision of the National Adult Reading Test. The Clinical Neuropsychologist, 3, 129-136.
7. Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64, 604-611.
8. Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000). Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743-753.
9. Brezden, C. B., Phillips, K. A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
10. Broadbent, D. E., Cooper, P. F., Fitzgerald, P., & Parkes, K. R. (1982). The Cognitive Failures Questionnaire and its correlates. British Journal of Clinical Psychology, 21, 1-16.
11. Castellon, S. A. & Ganz, P. A. (2001). Cognitive function following adjuvant therapy for breast cancer. Oncology, 15, 622-624
12. Chelebowski, R. T. (2000). Reducing the risk of breast cancer. New England Journal of Medicine, 343, 191-198.
13. Cull, A., Hay, C., Love, S. B., Mackie, M., Smets, E., & Stewart, M. (1996). What do patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679.
14. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. (1987). California Verbal Learning Test: Adult Version Manual. San Antonio, TX, The Psychological Corporation.
15. Ernst T., Chang L., Cooray D., Salvador C., Jovicich J., Walot I., et al. (2002). The effects of tamoxifen and estrogen on brain metabolism in elderly women. Journal of the National Cancer Institute, 94, 592-597
16. Fisher B., Costantino J. P., Wickerham D. L., Redmond C. K., Kavanah M., Cronin W. M., et al. (1998) Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Journal of the National Cancer Institute 90, 1371-1388.
17. Ganz, P. A. (1998). Cognitive dysfunction following adjuvant treatment of breast cancer: A new dose-limiting toxic effect?. Journal of the National Cancer Institute, 90, 182-183.
18. Ganz, P. A., Castellon, S. A., & Silverman, D. (2002). Estrogen, tamoxifen, and the brain. Journal of the National Cancer Institute, 94, 547-549.
19. Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39-49.
20. Grodstein, F., Chen, J., Pollen, D. A., Albert, M. S., Wilson, R. S., Folstein, M. F., et al. (2000). Post-menopausal hormone therapy and cognitive function in healthy older women. Journal of the American Geriatrics Society, 48, 746-752.
21. Gronwell, D. M. A. (1977). Paced auditory serial-addition task: A measure of recovery from concussion. Perceptual and Motor Skills, 44, 367-373.
22. Hinkin, C. H., vanGorp, W. G., Satz, P., Marcotte, T., Durvasula, R. S., Wood, S., et al. (1996). Actual versus self-reported cognitive dysfunction in HPV-1 infeciton: Memory-metamemory dissociations. Journal of Clinical and Experimental Neuropsychology, 18, 431-443.
23. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003). Cancer Statistics, 2003. CA Cancer J Clin, 53, 5-26.
24. Lezak, M. D. (1995). Neuropsychological Assessment, 3rd Edition.New York: Oxford University Press.
25. Mahoney, A. M., Dalby, J. T., & King, M. C. (1998). Cognitive failures and stress. Psychological Reports, 82, 1432-1434.
26. Maki P. M. & Resnick S.M. (2000). Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21, 373-383.
27. McKinney, M., Blake, H., Treece, K. A., Lincoln, N. B., Playford, E. D., & Gladman, J. R. F. (2002). Evaluation of cognitive assessment in stroke rehabilitation. Clinical Rehabilitation, 16, 129-136.
28. Meyers, C. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14,75-79.
29. Meyers, J. & Meyers, K. (1995). Rey-Complex Figure Test under four different administration procedures. The Clinical Neuropsychologist, 9, 63-67.
30. Miller, E. N., Satz, P., & Visscher, B. (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology, 41, 1608-1616.
31. Mitrushina, M. N., Boone, K. B., & D'Elia, L. F. (1999). Handbook of normative data for neuropsychological assessment. New York: Oxford University Press.
32. National Institutes of Health Consensus Development Conference (2001) Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. Journal of the National Cancer Institute, 93, 979-989.
33. Osterrieth, P. A. (1944). Le test de copie d' une figure complex: Contribution a l'etude de la perception et de la memoire [The Complex Figure Copy Test]. Archives de Psychologie, 30, 286-356.
34. Paganini-Hill, A., & Clark, L. J. (2000). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Research and Treatment, 64, 165-176.
35. Pakilit, A. T., Kahn, B. A., Petersen, L., Abraham, L. S., Greendale, G. A., & Ganz, P. A. (2001). Making effective use of tumor registries for cancer survivorship research. Cancer, 92, 1305-1314.
36. Reitan, R., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery. Tuscon, AZ: Neuropsychology Press.
37. Rey, A. (1942). L'examen psychologique dans les cas d' encephalopathie traumatique [The psychological examination in cases of traumatic brain injury]. Archives de Psychologie, 28, 286-340.
38. Rourke, S. B., Halman, M. H., & Bassei, C. (1999). Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. Journal of Clinical & Experimental Neuropsychology. 21, 737-756.
39. Schagen, S. B., vanDam, F. S., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
40. Shaywitz S. E., Shaywitz B. A., Pugh K. R., Fulbright R. K., Skudlarski P., Mencl W. E., et al (1999). Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA, 281, 1197-1202.
41. Sherwin, B. B. (1997). Estrogen effects on cognition in menopausal women. Neurology, 7, 21-26.
42. Sherwin, B. B. (1999). Can estrogen keep you smart? Evidence from clinical studies. Journal of Psychiatry and Neuroscience, 24, 315-321.
43. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. G. (1971). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Press.
44. SPSS, Inc. (1997). Statistical Package for the Social Sciences, Version 8.0. Chicago, SPSS Incorporated.
45. Sumner B. E., Grant, K. E., Rosie, R., Hegele-Hartung, C., Fritzemeir, K. H., & Fink, G. (1999). Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine (2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Research Molecular Brain Research, 73, 119-128
46. van Dam, F. S., Schagen, S. B., Muller, M. J, Boogerd, W., v.d Wall, E., Droogleever Fortuyn, M. E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
47. Vermeulen, J., Aldenkamp, A. P., & Alpherts, W. C. (1993). Memory complaints in epilepsy: correlations with cognitive performance and neuroticism. Epilepsy Research, 15, 157-170.
48. Wang, P. N., Liao, S. Q., Liu, R. S., Liu, C. Y., Chao, H. T., Lu, S. R., et al. (2000). Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology, 54, 2061-2066.
49. Ware, J. E. & Sherbourne, C. D. (1992). A 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30, 473-483.
50. Wechsler, D. (1987). Wechsler Memory Scale - Revised (WMS-R). San Antonio, TX: The Psychological Corporation.
51. Wechsler, D. (1991). Wechsler Adult Intelligence Scale - 3rd Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
52. Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology, 4, 61-66.
53. Yaffe, K., Lui, L. Y., Grady, D., & Beck, A. T. (2000). Cognitive decline in women in relation to nonprotein-bound oestradiol concentrations. Lancet, 356, 708.